This episode provides an in-depth review of key regulatory developments impacting sectors such as the ADRA project on veterinary antibiotics, banking supervision enhancements, cybersecurity risks linked to Claude Mythos, market abuse investigations, and antibiotic regulations.

The Bank of England has released a comprehensive operational guide on transfer resolution, clarifying governance arrangements and recapitalisation payment mechanisms to improve transparency and firm preparedness.

Authorities continue to prioritize cyber risk stress testing across EU and UK banks, incorporating scenario-based exercises and penetration testing to bolster operational resilience against sophisticated cyber threats.

The Autorité des marchés financiers (AMF) has confirmed the resumption of trading in Rapid Nutrition shares following suspension due to suspected market manipulation, urging investor vigilance.

For more information, visit the Carver Agents website.

Articles mentioned:

1. Operational guide to transfer resolution
2. CERTFR-2026-ACT-016 - Vulnérabilités et risques des produits d’automatisation par IA agentique
3. Cyber risk stress testing for banks
4. US and UK Regulators Warn Banks of AI Model Mythos' Cybersecurity Risks
5. The AMF confirms the resumption of trading in Rapid Nutrition shares
6. The AMF confirms the resumption of trading in Rapid Nutrition shares
7. Maßnahmen Bankenaufsicht
8. Implementation of the adjustments from the EU ADRA project
9. EU/3/25/3136 - Orphan designation for treatment of Glanzmann thrombasthenia | ozisiran
10. PSUSA/00000415/202508 - Periodic safety update report single assessment | biperiden